Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$1.5 - $4.59 $39,300 - $120,258
-26,200 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$3.89 - $5.15 $101,918 - $134,930
26,200 New
26,200 $105,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.2B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Guild Investment Management, Inc. Portfolio

Follow Guild Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guild Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Guild Investment Management, Inc. with notifications on news.